Pages that link to "Q35194758"
Jump to navigation
Jump to search
The following pages link to Mild cognitive impairment clinical trials (Q35194758):
Displaying 50 items.
- Cholinesterase inhibitors in mild cognitive impairment: a systematic review of randomised trials (Q21092367) (← links)
- Huperzine A for mild cognitive impairment (Q24202101) (← links)
- Huperzine A for mild cognitive impairment (Q24234330) (← links)
- Mild cognitive impairment: pathology and mechanisms. (Q24631255) (← links)
- APH-1a is the principal mammalian APH-1 isoform present in gamma-secretase complexes during embryonic development (Q28592373) (← links)
- BACE1, a major determinant of selective vulnerability of the brain to amyloid-beta amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. (Q30483997) (← links)
- High-throughput, fully automated volumetry for prediction of MMSE and CDR decline in mild cognitive impairment (Q30487873) (← links)
- Prediction of conversion from mild cognitive impairment to Alzheimer disease based on bayesian data mining with ensemble learning. (Q30666491) (← links)
- Mild cognitive impairment: an overview. (Q31143111) (← links)
- The impact of cognitive functioning on mortality and the development of functional disability in older adults with diabetes: the second longitudinal study on aging (Q33241638) (← links)
- Imaging of mild cognitive impairment and early dementia (Q33331183) (← links)
- Usefulness of event-related potentials in the assessment of mild cognitive impairment (Q33382870) (← links)
- The COMT Val158 Met polymorphism as an associated risk factor for Alzheimer disease and mild cognitive impairment in APOE 4 carriers (Q33507730) (← links)
- Mapping Alzheimer's disease progression in 1309 MRI scans: power estimates for different inter-scan intervals (Q33759240) (← links)
- Protein levels of heat shock proteins 27, 32, 60, 70, 90 and thioredoxin-1 in amnestic mild cognitive impairment: an investigation on the role of cellular stress response in the progression of Alzheimer disease (Q33857238) (← links)
- Identifying cognitively healthy elderly individuals with subsequent memory decline by using automated MR temporoparietal volumes (Q33863423) (← links)
- Sparse learning and stability selection for predicting MCI to AD conversion using baseline ADNI data (Q34316574) (← links)
- Pharmacological characterization of DM232 (unifiram) and DM235 (sunifiram), new potent cognition enhancers. (Q34546584) (← links)
- Long-term high-dose atorvastatin decreases brain oxidative and nitrosative stress in a preclinical model of Alzheimer disease: a novel mechanism of action (Q34556705) (← links)
- Biliverdin reductase--a protein levels and activity in the brains of subjects with Alzheimer disease and mild cognitive impairment. (Q34590312) (← links)
- Default mode network connectivity in stable vs progressive mild cognitive impairment (Q34646058) (← links)
- Synaptic change in the posterior cingulate gyrus in the progression of Alzheimer's disease (Q35035669) (← links)
- Elevated levels of pro-apoptotic p53 and its oxidative modification by the lipid peroxidation product, HNE, in brain from subjects with amnestic mild cognitive impairment and Alzheimer's disease (Q35458379) (← links)
- Do MCI criteria in drug trials accurately identify subjects with predementia Alzheimer's disease? (Q35484299) (← links)
- Reliability of a novel serious game using dual-task gait profiles to early characterize aMCI (Q35521983) (← links)
- Instrumental activities of daily living performance and role satisfaction in people with and without mild cognitive impairment: a pilot project (Q35676394) (← links)
- Dysexecutive syndrome in amnesic mild cognitive impairment: a multicenter study (Q36040668) (← links)
- Heme oxygenase-1 posttranslational modifications in the brain of subjects with Alzheimer disease and mild cognitive impairment (Q36041047) (← links)
- Hippocampal plasticity during the progression of Alzheimer's disease (Q36054541) (← links)
- Clinical trials in mild cognitive impairment: lessons for the future (Q36142255) (← links)
- Changes in everyday function in individuals with psychometrically defined mild cognitive impairment in the Advanced Cognitive Training for Independent and Vital Elderly Study (Q36298189) (← links)
- Disease progression model in subjects with mild cognitive impairment from the Alzheimer's disease neuroimaging initiative: CSF biomarkers predict population subtypes (Q36562471) (← links)
- Diagnosing Mild Cognitive Impairment (MCI) in clinical trials: a systematic review (Q36650249) (← links)
- Fibrillar and oligomeric beta-amyloid as distinct local biomarkers for Alzheimer's disease (Q36782620) (← links)
- Multimodal prediction of conversion to Alzheimer's disease based on incomplete biomarkers (Q36929004) (← links)
- Automated identification of dementia using medical imaging: a survey from a pattern classification perspective (Q36942783) (← links)
- Effects of oxidative and nitrosative stress in brain on p53 proapoptotic protein in amnestic mild cognitive impairment and Alzheimer disease (Q36984455) (← links)
- Can a direct IADL measure detect deficits in persons with MCI? (Q37128186) (← links)
- Oestrogen receptor polymorphisms are an associated risk factor for mild cognitive impairment and Alzheimer disease in women APOE {varepsilon}4 carriers: a case-control study. (Q37190255) (← links)
- Unbiased tensor-based morphometry: improved robustness and sample size estimates for Alzheimer's disease clinical trials (Q37203023) (← links)
- Neuropsychological characterization of mild cognitive impairment (Q37217932) (← links)
- Challenges in clinical research on Alzheimer's disease: Leon Thal's legacy (Q37218277) (← links)
- Rate of conversion from prodromal Alzheimer's disease to Alzheimer's dementia: a systematic review of the literature (Q37255097) (← links)
- Early diagnosis of Alzheimer's disease using cortical thickness: impact of cognitive reserve (Q37270617) (← links)
- Hierarchical interactions model for predicting Mild Cognitive Impairment (MCI) to Alzheimer's Disease (AD) conversion (Q37451840) (← links)
- Four-year outcome of mild cognitive impairment: the contribution of executive dysfunction. (Q37601466) (← links)
- Mild cognitive impairment in older adults (Q37658509) (← links)
- 'It's definitely not Alzheimer's': Perceived benefits and drawbacks of a mild cognitive impairment diagnosis. (Q39154054) (← links)
- Treatment strategies in Alzheimer's disease with a focus on early pharmacological interventions (Q39380813) (← links)
- Mild cognitive impairment should be considered for DSM-V. (Q40301859) (← links)